BIOMARKERS

Molecular Biopsy of Human Tumors

Biomarkers for Germ cell tumor

1. PER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
2. TP53
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
3. ELL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
4. CDKN2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
5. AKT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
6. MYC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
7. hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
8. BRAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
9. MYCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
10. EGFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
11. MAPK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
12. BCL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
13. NTRK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
14. RB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
15. NR4A3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
16. Ki-67
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
17. RET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
18. IL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
19. PIK3CA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
20. ESR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
21. CALCB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
22. PTEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
23. IDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
24. NF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
25. JUN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
26. AFP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
27. CTLA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
28. ER
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
29. PR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
30. MTOR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
31. AR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
32. ROS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
33. BRCA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
34. KIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
35. SDHB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
36. ERBB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
37. POU5F1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
38. FAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
39. Beta-hCG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
40. NRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
41. ENO2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
42. NF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
43. SDHD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
44. FGFR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
45. FBXW7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
46. SRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
47. MUC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
48. LDH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
49. CEACAM5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
50. STAT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
51. VHL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
52. IDH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
53. KDR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
54. CDK4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
55. TIMP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
56. APC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
57. MDM2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
58. MS4A1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
59. HIF1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
60. PDCD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
61. MITF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
62. HRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
63. GNAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
64. HLA-A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
65. CgA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
66. SMARCB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
67. TG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
68. MAX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
69. PTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
70. SPEN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
71. ATM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
72. SOX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
73. ABL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
74. CCDC6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
75. CDKN1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
76. FH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
77. RHOA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
78. EWSR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
79. CXCR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
80. FANCA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
81. TERT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
82. TSC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
83. PDGFRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
84. PTPRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
85. ITK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
86. POLE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
87. MLH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
88. SDHC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
89. MET
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
90. SERPINE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
91. MEN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
92. ALK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
93. NBN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
94. KRAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
95. MUC16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
96. CD274
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
97. TP63
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
98. MAP2K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
99. CUX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
100. PRKAR1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
101. RAC1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
102. RAF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
103. BRCA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
104. ABL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
105. ARID1B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
106. FOXP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
107. MSH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
108. PDGFRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
109. BRD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
110. PPFIBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
111. SDHA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
112. uPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
113. FUS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
114. HSP90AA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
115. MYB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
116. WT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
117. NKX2-1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
118. DDIT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
119. MDM4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
120. RHOH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
121. ABCG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
122. CALR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
123. GNAQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
124. NOTCH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
125. BLM
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
126. PDGFB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
127. PRF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
128. CDK6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
129. TSC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
130. ATRX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
131. CREBBP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
132. BCR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
133. RARA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
134. CCND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
135. CD79A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
136. ERBB3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
137. OLIG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
138. NCKIPSD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
139. SMAD3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
140. PSA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
141. BAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
142. ERG
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
143. CDKN2C
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
144. GOPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
145. EZH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
146. CHEK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
147. CTNNB1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
148. GNA11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
149. SMAD4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
150. NFE2L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
151. CASP8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
152. STK11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
153. KLF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
154. FLI1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
155. TRA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
156. SMAD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
157. FGFR3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
158. NT5C2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
159. PTPN11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
160. CDH1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
161. MSH6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
162. Neurokinin
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
163. NTRK3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
164. PAX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
165. EP300
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
166. SMO
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
167. PML
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
168. RECQL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
169. JAK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
170. ERBB4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
171. FOXO3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
172. CIC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
173. PHOX2B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
174. STIL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
175. SDHAF2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
176. DICER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
177. CDX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
178. STAT5B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
179. TMEM127
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
180. IL6ST
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
181. KIAA1549
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
182. SALL4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
183. NOTCH2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
184. ATR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
185. REL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
186. ERCC2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
187. FLT4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
188. H3F3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
189. SSX2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
190. SMARCA4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
191. RANBP2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
192. PMS2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
193. TBX3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
194. FOXO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
195. WAS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
196. CBL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
197. HMGA2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
198. KMT2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
199. FGFR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
200. GATA3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
201. YWHAE
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
202. AKT2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
203. EPAS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
204. PAX8
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
205. CLIP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
206. CYLD
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
207. DAXX
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
208. MYOD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
209. ETV5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
210. FANCD2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
211. CIITA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
212. GPC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
213. CDH11
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
214. SOCS1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
215. AXIN1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
216. FLCN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
217. FUBP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
218. JAK1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
219. CARS
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
220. ELN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
221. SUFU
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
222. TRIM27
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
223. FLT3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
224. CCND2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
225. ETV6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
226. KLF6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
227. LMNA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
228. NPM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
229. ACVR1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
230. TFRC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
231. ELF4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
232. MAP2K2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
233. MYD88
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
234. NRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
235. PAX5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
236. PPM1D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
237. NDRG1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
238. ARNT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
239. ATF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
240. HIST1H3B
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
241. MSN
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
242. SF3B1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
243. U2AF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
244. BIRC3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
245. FHIT
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
246. IGH
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
247. TRRAP
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
248. TOP2A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
249. CTCF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
250. DNMT3A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
251. ERCC4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
252. FEV
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
253. TNFAIP3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
254. XPC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
255. ERCC5
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
256. FES
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
257. FGFR4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
258. LCK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
259. SND1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
260. SYK
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
261. TFE3
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
262. HMGA1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
263. PIK3R1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
264. TRB
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
265. ETV4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
266. HEY1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
267. KMT2D
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
268. RUNX1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
269. SFPQ
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
270. TGFBR2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
271. WIF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
272. XPA
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
273. XPO1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
274. ARID1A
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
275. KEAP1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
276. KLK2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
277. LIFR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
278. MAP2K4
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
279. MYCL
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
280. NUTM1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
281. RPL22
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
282. TCF7L2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
283. TPR
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
284. B2M
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
285. HOXA9
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
286. IL7R
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
287. PALB2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
288. PCSK7
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
289. PDCD1LG2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
290. TAL1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
291. HER1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
292. LEF1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
293. MAF
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
294. MAP3K1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
295. SS18
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
296. STAT6
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
297. ZBTB16
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
298. CDC73
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
299. EXT1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
300. FANCC
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
301. FOXL2
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
302. NSD1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
303. SUZ12
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
304. CCNE1
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
305. CD74
    [Clinical Outcome] [Diagnosis] [Prognosis] [Staging] [Treatment]
306. CREB1
    [